Stock Price
2.35
Daily Change
0.05 2.17%
Monthly
-11.32%
Yearly
-4.47%
Q1 Forecast
2.36

Mesoblast reported $2.68B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Avita Medical AUD 140.79M 194.8M Jun/2025
Clinuvel Pharmaceuticals AUD 520.28M 83.45M Jun/2025
Cochlear AUD 19.65B 679.76M Jun/2025
CSL USD 76.3B 60.04B Jun/2025
Pacific Edge NZD 194.21M 87.84M Dec/2025
Paradigm Biopharmaceuticals AUD 118.78M 27.21M Jun/2025
PYC Therapeutics AUD 755.32M 139.4M Jun/2025
Sonic Healthcare AUD 12.87B 105.69M Jun/2025
Telix Pharmaceuticals AUD 2.96B 2.11B Feb/2026